The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and circulating protein biomarkers of second-line aflibercept plus FOLFIRI according to prior bevacizumab or cetuximab treatment in advanced colorectal cancer (KCSG CO21-21).
 
Hyunwook Kim
No Relationships to Disclose
 
Colin Burdette
No Relationships to Disclose
 
Ho Jung An
No Relationships to Disclose
 
Sang Hee Cho
No Relationships to Disclose
 
Seok Yun Kang
No Relationships to Disclose
 
Myung Ah Lee
Honoraria - Merck; Takeda
Consulting or Advisory Role - Green Cross; Handok; onconic therapeutics
 
In Kyu Hwang
No Relationships to Disclose
 
Tae Won Kim
Employment - Asan Medical Center
Research Funding - Inocras (Inst); Roche/Genentech (Inst)
 
Cheol-Sik Kim
No Relationships to Disclose
 
Jong Gwang Kim
No Relationships to Disclose
 
Jung Yong Hong
Honoraria - AstraZeneca; Bristol-Myers Squibb; Dong-A Socio; Menarini; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Eisai; Elevar Therapeutics; Handok; ImmuneOncia; Roche
 
Moon Ki Choi
Honoraria - Boryung
Consulting or Advisory Role - Celltrion Pharm; Guardant Health; Natera; Takeda
 
Sang Cheul Oh
No Relationships to Disclose
 
Seung-Hoon Beom
Honoraria - Astellas Pharma; Jeil Pharmaceutical Co; Takeda
Consulting or Advisory Role - Amgen; Astellas Pharma; Guardant Health; IMBdx; Jeil Pharmaceutical Co; Ono Pharmaceutical
Research Funding - Amgen (Inst); Bayer (Inst); IgM Biosciences (Inst); Jeil Pharmaceutical Co (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); MSD (Inst); Pfizer (Inst); Revolution Medicines (Inst); Roche (Inst); ST Cube (Inst); Takeda (Inst)
 
Sang Joon Shin
No Relationships to Disclose
 
Jacob Geri
No Relationships to Disclose
 
Han Sang Kim
No Relationships to Disclose
 
Joong Bae Ahn
Research Funding - Merck; Sanofi